Related Experiment Video

Updated: Sep 10, 2025

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
10:55

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

11.2K

Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation

Joyeeta Talukdar1, Arnab Nayek1, Gayatri Gogoi2

  • 1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Discover Oncology
|August 25, 2025
PubMed

Insights

This study explores how the Decoy receptor for chemokines (DARC) interacts with CCL8, c-MYC, ALDH1, and CHEK2 in breast cancer. These complex relationships influence tumor growth and metastasis, potentially revealing new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Atypical chemokine receptor 1 (ACKR1), also known as the Decoy receptor for chemokines (DARC), is implicated in cancer progression.
  • DARC's roles in tumor growth, angiogenesis, and metastasis are increasingly recognized.
  • Understanding DARC's interactions with other molecular markers is crucial for targeted breast cancer therapies.

Purpose of the Study:

  • To investigate the interplay between DARC and key molecular markers (CCL8, c-MYC, ALDH1, CHEK2) in breast cancer.
  • To elucidate the collective impact of these markers on breast cancer behavior.
  • To identify potential therapeutic targets based on these molecular interactions.

Main Methods:

  • Analysis of gene and protein expression patterns in breast cancer tissues.
  • Correlation studies to assess the relationships between DARC and the selected molecular markers.
  • Bioinformatic analysis to understand the functional implications of observed interactions.

Main Results:

  • Complex interaction patterns identified between DARC and CCL8, c-MYC, ALDH1, and CHEK2 in breast cancer.
  • Evidence suggests synergistic roles of DARC and these markers in promoting or inhibiting tumor progression.
  • Specific expression profiles correlate with distinct aspects of tumor behavior.

Conclusions:

  • The interplay between DARC and molecular markers like CCL8, c-MYC, ALDH1, and CHEK2 significantly influences breast cancer.
  • These findings highlight the potential of targeting DARC-mediated pathways for personalized breast cancer treatment.
  • Further research into these complex interactions could pave the way for novel therapeutic strategies.

More Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.5K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.1K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K